Secondary prevention of coronary artery disease in patients undergoing elective surgery for peripheral arterial disease

Caitlin M. Nass, Jerilyn K. Allen, Roland M. Jermyn, Lee A. Fleisher

Research output: Contribution to journalArticle

Abstract

The purpose of the study was to assess the implementation of secondary prevention guidelines of coronary artery disease (CAD) in patients undergoing peripheral revascularization surgery. The design was a descriptive study of the prevalence of cardiac risk factors and preventive pharmacological therapy in vascular surgical patients set in an academic medical center between July 1996 and February 1999. A total of 237 patients were recruited, 82 (35%) having carotid surgery and 155 (65%) having lower extremity bypass. Data were collected from an existing database of a study examining perioperative cardiac events in vascular surgery patients. The majority of patients were hypertensive and 58% of patients had a blood pressure >140/90 mmHg. Most patients (81%) reported a history of tobacco use and 23% were active smokers. Of the 41% of patients who were diabetic, 46% had a random glucose >140 mg/dl. Half of the patients took aspirin, 35% a lipid-lowering medication, 30% a beta-blocker. Patients with lower extremity disease were less likely than patients with carotid disease to be on aspirin (45% vs. 62%), a lipid-lowering agent (30% vs. 45%), or a beta-blocker (26% vs. 39%) (all p

Original languageEnglish (US)
Pages (from-to)35-41
Number of pages7
JournalVascular Medicine
Volume6
Issue number1
DOIs
StatePublished - 2001

Fingerprint

Peripheral Arterial Disease
Secondary Prevention
Coronary Artery Disease
Aspirin
Blood Vessels
Lower Extremity
Lipids
Tobacco Use
Cross-Sectional Studies
Databases
Pharmacology
Guidelines
Blood Pressure
Glucose

Keywords

  • CAD
  • PAD
  • Secondary prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Secondary prevention of coronary artery disease in patients undergoing elective surgery for peripheral arterial disease. / Nass, Caitlin M.; Allen, Jerilyn K.; Jermyn, Roland M.; Fleisher, Lee A.

In: Vascular Medicine, Vol. 6, No. 1, 2001, p. 35-41.

Research output: Contribution to journalArticle

@article{c2c0102aedda49f08bf2cc603166ec48,
title = "Secondary prevention of coronary artery disease in patients undergoing elective surgery for peripheral arterial disease",
abstract = "The purpose of the study was to assess the implementation of secondary prevention guidelines of coronary artery disease (CAD) in patients undergoing peripheral revascularization surgery. The design was a descriptive study of the prevalence of cardiac risk factors and preventive pharmacological therapy in vascular surgical patients set in an academic medical center between July 1996 and February 1999. A total of 237 patients were recruited, 82 (35{\%}) having carotid surgery and 155 (65{\%}) having lower extremity bypass. Data were collected from an existing database of a study examining perioperative cardiac events in vascular surgery patients. The majority of patients were hypertensive and 58{\%} of patients had a blood pressure >140/90 mmHg. Most patients (81{\%}) reported a history of tobacco use and 23{\%} were active smokers. Of the 41{\%} of patients who were diabetic, 46{\%} had a random glucose >140 mg/dl. Half of the patients took aspirin, 35{\%} a lipid-lowering medication, 30{\%} a beta-blocker. Patients with lower extremity disease were less likely than patients with carotid disease to be on aspirin (45{\%} vs. 62{\%}), a lipid-lowering agent (30{\%} vs. 45{\%}), or a beta-blocker (26{\%} vs. 39{\%}) (all p",
keywords = "CAD, PAD, Secondary prevention",
author = "Nass, {Caitlin M.} and Allen, {Jerilyn K.} and Jermyn, {Roland M.} and Fleisher, {Lee A.}",
year = "2001",
doi = "10.1191/135886301671753754",
language = "English (US)",
volume = "6",
pages = "35--41",
journal = "Vascular Medicine",
issn = "1358-863X",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Secondary prevention of coronary artery disease in patients undergoing elective surgery for peripheral arterial disease

AU - Nass, Caitlin M.

AU - Allen, Jerilyn K.

AU - Jermyn, Roland M.

AU - Fleisher, Lee A.

PY - 2001

Y1 - 2001

N2 - The purpose of the study was to assess the implementation of secondary prevention guidelines of coronary artery disease (CAD) in patients undergoing peripheral revascularization surgery. The design was a descriptive study of the prevalence of cardiac risk factors and preventive pharmacological therapy in vascular surgical patients set in an academic medical center between July 1996 and February 1999. A total of 237 patients were recruited, 82 (35%) having carotid surgery and 155 (65%) having lower extremity bypass. Data were collected from an existing database of a study examining perioperative cardiac events in vascular surgery patients. The majority of patients were hypertensive and 58% of patients had a blood pressure >140/90 mmHg. Most patients (81%) reported a history of tobacco use and 23% were active smokers. Of the 41% of patients who were diabetic, 46% had a random glucose >140 mg/dl. Half of the patients took aspirin, 35% a lipid-lowering medication, 30% a beta-blocker. Patients with lower extremity disease were less likely than patients with carotid disease to be on aspirin (45% vs. 62%), a lipid-lowering agent (30% vs. 45%), or a beta-blocker (26% vs. 39%) (all p

AB - The purpose of the study was to assess the implementation of secondary prevention guidelines of coronary artery disease (CAD) in patients undergoing peripheral revascularization surgery. The design was a descriptive study of the prevalence of cardiac risk factors and preventive pharmacological therapy in vascular surgical patients set in an academic medical center between July 1996 and February 1999. A total of 237 patients were recruited, 82 (35%) having carotid surgery and 155 (65%) having lower extremity bypass. Data were collected from an existing database of a study examining perioperative cardiac events in vascular surgery patients. The majority of patients were hypertensive and 58% of patients had a blood pressure >140/90 mmHg. Most patients (81%) reported a history of tobacco use and 23% were active smokers. Of the 41% of patients who were diabetic, 46% had a random glucose >140 mg/dl. Half of the patients took aspirin, 35% a lipid-lowering medication, 30% a beta-blocker. Patients with lower extremity disease were less likely than patients with carotid disease to be on aspirin (45% vs. 62%), a lipid-lowering agent (30% vs. 45%), or a beta-blocker (26% vs. 39%) (all p

KW - CAD

KW - PAD

KW - Secondary prevention

UR - http://www.scopus.com/inward/record.url?scp=0035035850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035035850&partnerID=8YFLogxK

U2 - 10.1191/135886301671753754

DO - 10.1191/135886301671753754

M3 - Article

C2 - 11358159

AN - SCOPUS:0035035850

VL - 6

SP - 35

EP - 41

JO - Vascular Medicine

JF - Vascular Medicine

SN - 1358-863X

IS - 1

ER -